SEC Form D private-offering filing

Biovantix Biotechnology, Inc

Name: Biovantix Biotechnology, Inc - new SEC Form D private-offering filing, Dover, DE
Published: 2025-10-17

A new SEC Form D private-offering notice from Dover, DE, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Biovantix Biotechnology, Inc Verified via SEC Form D

Biotechnology platform company developing an AI enhanced nanoplatform for biologic drug delivery.

Filed 2025-10-17Filed to raise $15,000,000HQ (as filed) Dover, DESector Biotech ✓Stage (inferred) EarlyCall status No reported sale

Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Delaware →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.